Computational Modeling of Right Ventricular Intracardiac Flow in Tetralogy of Fallot

法洛四联症右心室心内血流的计算模型

基本信息

  • 批准号:
    10318212
  • 负责人:
  • 金额:
    $ 24.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-12-15 至 2023-11-30
  • 项目状态:
    已结题

项目摘要

1 Tetralogy of Fallot is the most common form of cyanotic heart disease, typically surgically corrected in early 2 infancy. However, a majority of survivors with repaired Tetralogy of Fallot (rTOF) will suffer from long-standing 3 pulmonary insufficiency, right ventricular (RV) enlargement, and require pulmonary valve replacement (PVR) 4 as a teenager or young adult. The timing of the procedure has been historically determined by cardiac 5 magnetic resonance imaging (cMRI). However, the timing of PVR is controversial, as there are variable CMR 6 criteria for PVR, valve replacements have limited durability, and there is no method to determine the 7 hemodynamic benefit of PVR. Computational fluid dynamics (CFD) simulation is key to this dilemma, as CFD 8 been used to simulate and guide other forms of congenital heart surgery. 9 The overall objective of the proposed research is to create a simulation of abnormal flow in rTOF patients using 10 cMRI data. We hypothesize that we can detect important flow abnormalities in rTOF patients, prior to PVR, 11 through our unique CFD solver using cMRI data. When compared to other forms of CFD, our method is 12 unique as it simulates flow inside a moving RV and relies only on cMRI data. We plan on addressing our 13 hypothesis by using cMRI data to create comprehensive simulations of 50 rTOF patients. 14 The specific objectives of this application include: 1) To reconstruct RV wall motion with cMRI data, 2) To 15 simulate RV intracardiac flow in a cohort of rTOF patients, 3) To validate CFD solver results with in-vivo cMRI 16 measurements in the form of three-dimensional velocity-encoded phase contrast (4D flow). 17 The results from this work will validate our fully developed, comprehensive CFD solver of RV flow in rTOF 18 patients. Future work would utilize this solver to develop a prediction model for PVR. With the increasing use of 19 PVR and growing adult population of rTOF, this work will have significant impact on their overall care, providing 20 clinicians with flow biomarkers that may predict the benefit of PVR and guide therapy.
法洛四联症是最常见的紫绀型心脏病,通常在早期手术矫正。 2婴儿期然而,大多数法洛四联症(rTOF)修复后的幸存者将遭受长期的 3例肺功能不全,右心室(RV)扩大,需行肺动脉瓣置换术(PVR) 4作为青少年或年轻人。手术的时间历来由心脏决定。 5磁共振成像(cMRI)。然而,PVR的时间是有争议的,因为有可变的CMR PVR的6个标准,瓣膜置换术的耐久性有限,并且没有方法确定 7 PVR的血流动力学益处。计算流体动力学(CFD)模拟是解决这一难题的关键, 8被用于模拟和指导其他形式的先天性心脏病手术。 9.拟议研究的总体目标是使用以下方法模拟rTOF患者的异常血流: 10例cMRI数据。我们假设我们可以在PVR之前检测到rTOF患者的重要血流异常, 11通过我们独特的CFD求解器使用cMRI数据。与其他形式的CFD相比,我们的方法 12独特,因为它模拟了移动RV内的流动,并且仅依赖于cMRI数据。我们计划解决 使用cMRI数据创建50例rTOF患者的综合模拟。 14本申请的具体目标包括:1)使用cMRI数据重建RV室壁运动,2) 15模拟rTOF患者队列中的RV心内血流,3)使用体内cMRI验证CFD求解器结果 以三维速度编码相位对比(4D流)的形式进行16次测量。 17这项工作的结果将验证我们完全开发的rTOF中RV流的综合CFD求解器 18个病人未来的工作将利用此求解器开发PVR的预测模型。随着越来越多地使用 19 PVR和不断增长的rTOF成人人口,这项工作将对他们的整体护理产生重大影响, 20名临床医生的血流生物标志物可预测PVR的获益并指导治疗。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Abnormal Diastolic Hemodynamic Forces: A Link Between Right Ventricular Wall Motion, Intracardiac Flow, and Pulmonary Regurgitation in Repaired Tetralogy of Fallot.
  • DOI:
    10.3389/fcvm.2022.929470
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Loke, Yue-Hin;Capuano, Francesco;Kollar, Sarah;Cibis, Merih;Kitslaar, Pieter;Balaras, Elias;Reiber, Johan H. C.;Pedrizzetti, Gianni;Olivieri, Laura
  • 通讯作者:
    Olivieri, Laura
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yue-Hin Loke其他文献

Yue-Hin Loke的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 24.88万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.88万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 24.88万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.88万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 24.88万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.88万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 24.88万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 24.88万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 24.88万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.88万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了